🟢 Hims & Hers Health is trading 5% up on October 9, 2026 with no clear catalyst

Hims & Hers Health is trading at €26.00, up 5.26%, with no clear company-specific catalyst identified for the October 9 move.

• Recent coverage points to a rebound after the prior session’s sharp decline, amid ongoing legal and regulatory concerns; this context does not establish the cause of the gain.
• Healthcare is reported up 1.33%, while major U.S. indices are up less than 0.5%; these provide market context but do not confirm the stock’s driver.